acide valérénique, avec analyt. Documents, 100 mg, emballage en verre

3-((3-(N-Cyclopropylsulfamoyl)-7-(2,4-dimethoxypyrimidin-5-yl)quinolin-4-yl)amino)-5-(3,5-difluorophenoxy)benzoic acid, 98%, 10mg

trans,trans-4-Methoxy-4-n-propyl-1,1-bicyclohexyl, 97%, 25g

3-Bromo-5-nitrobenzaldehyde, 95.0%, 25g

4-Boc-6-Amino-1,4-oxazepane, 95.0%, 100mg

tert-Butyl 5-chlorospiro[indoline-3,4'-piperidine]-1'-carboxylate, 95.0%, 1g

N-(3-Fluorophenyl)pivalamide, 95.0%, 25g

2-Butyl-1,3,2-dioxaborolane-4S,5S-dicarboxylic acid bis(dimethylamide), 97.0%, 5g

N-(4-aminophenyl)-3-methylbenzamide, 100mg

tert-Butyl (4-ethylpiperidin-4-yl)methylcarbamate, 1g

(3-Bromo-2-ethoxyphenyl)methanol, 98%, 1g

5-(Trifluoromethyl)pyrazin-2-ol, 95.0%, 5g

Ibutilide Hemifumarate>98.0%(HPLC)(N)100mg